TXUG - ETF AI Analysis
Top Page
Thornburg International Growth Fund ETF (TXUG)
TXUG’s rating suggests it is a solid but not top-tier international growth ETF, supported by strong core holdings like ASML and AstraZeneca, which show robust financial performance and positive business outlooks. Other key positions such as Mastercard and Shopify also add to the fund’s appeal through strong growth and earnings, though their high valuations and some bearish technical signals introduce risk. Overall, the main risk factor is that many of the fund’s major holdings appear expensive and sometimes show weak or mixed technical trends, which can increase volatility.
TXUG vs. SPDR S&P 500 ETF (SPY)
- AUM
- 4.28M
- Region
- Developed Markets
- Expense Ratio
- 0.70%
- Beta
- 0.98
- Issuer
- Thornburg
- Inception Date
- Jan 22, 2025
- Dividend Yield
- 0.48%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
TXUG Summary
TXUG, the Thornburg International Growth Fund ETF, focuses on growth companies from around the world rather than tracking a specific index. It invests in a mix of industries, including technology, industrials, health care, and consumer companies, with holdings spread across the U.S., Europe, and Asia. Well-known names in the fund include Advanced Micro Devices (AMD), Mastercard, and AstraZeneca, giving investors exposure to established global businesses with room to grow. Someone might invest in TXUG to diversify beyond the U.S. and seek long-term growth. A key risk is that growth stocks and international markets can be more volatile, so the value of the ETF can go up and down significantly.
How much will it cost me?
TXUG has an expense ratio of 0.70%, which means you’ll pay about $7 per year for every $1,000 invested. This cost is higher than the average ETF because it’s actively managed, with professionals selecting international growth stocks rather than simply tracking an index.
What would affect this ETF?
TXUG could benefit if developed markets outside the U.S. continue to grow, especially in technology, industrials, and health care, which would support companies like ASML, AMD, and AstraZeneca and help the fund’s growth-focused strategy. On the downside, higher interest rates, slower global economic growth, or stricter regulations on tech and financial firms could hurt these sectors and make growth stocks in developed markets ex-U.S. more volatile.
TXUG Top 10 Holdings
TXUG leans heavily into global growth stories, with chipmaker AMD and Dutch semiconductor giant ASML acting as key engines for performance thanks to their strong year-to-date runs, even if recent trading has been a bit choppy. On the flip side, Rolls-Royce has been lagging, and AstraZeneca looks like it’s losing some steam, modestly weighing on results. The fund also gets a lift from rising names like Mastercard and Shopify, adding a tech-and-digital-payments flavor. Overall, it’s a developed-markets, ex-U.S. play with a clear tilt toward innovative industrial and tech leaders.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 8.17% | $349.40K | EUR 539.67B | 50.70% | 76Outperform |
 JP:7741 | HOYA | 4.88% | $208.70K | JPY 8.76T | 8.19% | 74Outperform |
 AMD | Advanced Micro Devices | 4.77% | $203.91K | $824.07B | 98.09% | 73Outperform |
 GB:RR | Rolls-Royce Holdings | 3.58% | $153.10K | GBP 102.49B | 6.11% | 71Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 CH:LONN | Lonza Group Ltd | 3.28% | $140.27K | CHF 43.90B | 15.37% | 71Outperform |
 MA | Mastercard | 3.20% | $136.68K | $559.19B | 15.23% | 75Outperform |
 FR:AI | Air Liquide | 3.19% | $136.23K | EUR 115.22B | 16.68% | 66Neutral |
 SHOP | Shopify | ― | ― | ― | ― | 77Outperform |
 RACE | Ferrari | ― | ― | ― | ― | 72Outperform |
TXUG Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TXUG, the sentiment is Negative. The current price of 26.06 is below the 20-day moving average (MA) of 26.77, below the 50-day MA of 27.09, and below the 200-day MA of 26.24, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 40.73 is Neutral, neither overbought nor oversold. The STOCH value of 73.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TXUG.
TXUG Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| TXUG | $26.06 | $28.00(7.45% Upside) | $4.28M | 0.70% | 64Neutral |
 INEQ | $39.03 | $46.42(18.93% Upside) | $92.71M | 0.45% | 66Neutral |
 IQGR | $24.04 | $29.90(24.37% Upside) | $24.16M | 0.58% | 60Neutral |
 RWIN | $27.29 | $32.29(18.32% Upside) | $20.54M | 0.42% | 66Neutral |
 LCIV | $26.10 | ― | $20.25M | 0.99% | 67Neutral |
 FFDI | $30.58 | $38.53(25.97% Upside) | $18.65M | 0.55% | 67Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TXUG | Thornburg International Growth Fund ETF | 26.06 | 1.25 | 5.04% | |
| INEQ | Columbia International Equity Income Etf | 39.03 | 5.17 | 15.26% | |
| IQGR | Astoria International Quality Growth Kings ETF | 24.04 | -0.93 | -3.74% | |
| RWIN | Rayliant NxtGen Multifactor International Equity ETF | 27.29 | 1.57 | 6.08% | |
| LCIV | Logan Capital International ETF | 26.10 | 1.27 | 5.11% | |
| FFDI | Fidelity Fundamental Developed International ETF | 30.58 | 1.27 | 4.31% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.